Ab­b­Vie ac­cus­es ri­val of steal­ing block­buster ‘trade se­crets’ as clock ticks down on biosim­i­lar as­sault

Two years be­fore the first biosim­i­lars to megablock­buster Hu­mi­ra are ex­pect­ed to hit the US mar­ket, Ab­b­Vie is tak­ing one de­vel­op­er to court over al­le­ga­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA